Role of Functional Imaging in the Management of Lymphoma von Cheson, Bruce D

Volltext

PET/CT in Lymphoma: Current Overview and Future Directions von Cheson, Bruce D.

Volltext

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification von Cheson, Bruce D, Fisher, Richard I, Barrington, Sally F, Cavalli, Franco, Schwartz, Lawrence H, Zucca, Emanuele, Lister, T Andrew

Volltext

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL von Hallek, Michael, Cheson, Bruce D., Catovsky, Daniel, Caligaris-Cappio, Federico, Dighiero, Guillermo, Döhner, Hartmut, Hillmen, Peter, Keating, Michael, Montserrat, Emili, Chiorazzi, Nicholas, Stilgenbauer, Stephan, Rai, Kanti R., Byrd, John C., Eichhorst, Barbara, O'Brien, Susan, Robak, Tadeusz, Seymour, John F., Kipps, Thomas J.

Volltext

Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy von Cheson, Bruce D., Ansell, Stephen, Schwartz, Larry, Gordon, Leo I., Advani, Ranjana, Jacene, Heather A., Hoos, Axel, Barrington, Sally F., Armand, Philippe

Volltext

Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies von CHESON, Bruce D

Volltext

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma von Cheson, Bruce D, Leonard, John P

Volltext

Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202) von RUBENSTEIN, James L, HSI, Eric D, JOHNSON, Jeffrey L, JUNG, Sin-Ho, NAKASHIMA, Megan O, GRANT, Barbara, CHESON, Bruce D, KAPLAN, Lawrence D

Volltext

Positron-Emission Tomography and Assessment of Cancer Therapy von Juweid, Malik E, Cheson, Bruce D

Volltext

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis von Mato, Anthony R, Nabhan, Chadhi, Thompson, Meghan C, Lamanna, Nicole, Brander, Danielle M, Hill, Brian, Howlett, Christina, Skarbnik, Alan, Cheson, Bruce D, Zent, Clive, Pu, Jeffrey, Kiselev, Pavel, Goy, Andre, Claxton, David, Isaac, Krista, Kennard, Kaitlin H, Timlin, Colleen, Landsburg, Daniel, Winter, Allison, Nasta, Sunita D, Bachow, Spencer H, Schuster, Stephen J, Dorsey, Colleen, Svoboda, Jakub, Barr, Paul, Ujjani, Chaitra S

Volltext

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group von Barrington, Sally F, Mikhaeel, N George, Kostakoglu, Lale, Meignan, Michel, Hutchings, Martin, Müeller, Stefan P, Schwartz, Lawrence H, Zucca, Emanuele, Fisher, Richard I, Trotman, Judith, Hoekstra, Otto S, Hicks, Rodney J, O'Doherty, Michael J, Hustinx, Roland, Biggi, Alberto, Cheson, Bruce D

Volltext

Speed bumps on the road to a chemotherapy-free world for lymphoma patients von Cheson, Bruce D.

Volltext

Bendamustine: Rebirth of an Old Drug von CHESON, Bruce D, RUMMEL, Mathias J

Volltext

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label,... von Sehn, Laurie H, Dr, Chua, Neil, MD, Mayer, Jiri, Prof, Dueck, Gregg, MD, Trněný, Marek, Prof, Bouabdallah, Kamal, MD, Fowler, Nathan, MD, Delwail, Vincent, MD, Press, Oliver, Prof, Salles, Gilles, MD, Gribben, John, Prof, Lennard, Anne, MBBS, Lugtenburg, Pieternella J, MD, Dimier, Natalie, MSc, Wassner-Fritsch, Elisabeth, PharmD, Fingerle-Rowson, Günter, MD, Cheson, Bruce D, Prof

Volltext

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma von YOUNES, Anas, GOPAL, Ajay K, FORERO-TORRES, Andres, MOSKOWITZ, Craig H, CONNORS, Joseph M, ENGERT, Andreas, LARSEN, Emily K, KENNEDY, Dana A, SIEVERS, Eric L, CHEN, Robert, SMITH, Scott E, ANSELL, Stephen M, ROSENBLATT, Joseph D, SAVAGE, Kerry J, RAMCHANDREN, Radhakrishnan, BARTLETT, Nancy L, CHESON, Bruce D, DE VOS, Sven

Volltext

Diffuse large B-cell lymphoma: new targets and novel therapies von Cheson, Bruce D., Nowakowski, Grzegorz, Salles, Gilles

Volltext

PI3K Signaling Pathway in Normal B Cells and Indolent B Cell Malignancies von Pongas, Georgios, M.D, Cheson, Bruce D., M.D

Volltext

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer In... von Hallek, Michael, Cheson, Bruce D., Catovsky, Daniel, Caligaris-Cappio, Federico, Dighiero, Guillaume, Döhner, Hartmut, Hillmen, Peter, Keating, Michael J., Montserrat, Emili, Rai, Kanti R., Kipps, Thomas J.

Volltext

Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia von Rogers, Kerry A., Thompson, Philip A., Allan, John N., Coleman, Morton, Sharman, Jeff P., Cheson, Bruce D., Jones, Daniel, Izumi, Raquel, Frigault, Melanie M., Quah, Cheng, Raman, Rakesh K., Patel, Priti, Wang, Min Hui, Kipps, Thomas J.

Volltext

CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET von Straus, David J., Jung, Sin-Ho, Pitcher, Brandelyn, Kostakoglu, Lale, Grecula, John C., Hsi, Eric D., Schöder, Heiko, Popplewell, Leslie L., Chang, Julie E., Moskowitz, Craig H., Wagner-Johnston, Nina, Leonard, John P., Friedberg, Jonathan W., Kahl, Brad S., Cheson, Bruce D., Bartlett, Nancy L.

Volltext